United Kingdom has issued multiple technical barrier and sanitary notifications concerning pesticides and dimethomorph to affected trading partners including Ireland.
Britain’s Health and Safety Executive (HSE) has withdrawn approval of the fungicide dimethomorph, a crop chemical found to harm fertility. The approval ends on 30 November 2026, and farmers must stop using remaining stocks by 31 May 2028.
The HSE, the agency that regulates pesticides in Great Britain, signed its final decision on 16 October 20261. It affects firms that hold authorisations for products containing dimethomorph, along with the distributors and growers who sell or use them. Sales must end by 31 May 2027, and the HSE will update its register of approved substances to reflect the decision1.
| At a glance | Details |
|---|---|
| What was published | Final decision withdrawing approval of the fungicide dimethomorph |
| Published on | 16 October 2026 (decision date) |
| Who must comply | Holders of product authorisations, distributors and users of dimethomorph products in Great Britain |
| Effective date | 30 November 2026 (approval ends) |
| Next milestone | Sales and distribution end 31 May 2027. Storage, disposal and use end 31 May 2028 |
What is dimethomorph, and why is it being removed?
Dimethomorph is a fungicide, a chemical that protects crops from fungal disease1. It was first approved on 1 October 20071. Its approval in Great Britain had been due to run until 31 July 20271.
The decision in brief
| Dimension | Provision |
|---|---|
| Substance | Dimethomorph, a crop fungicide |
| Authority | Health and Safety Executive (HSE) |
| Reason one | Toxic to reproduction, effects on fertility |
| Reason two | Disrupts human hormones |
| Approval ends | 30 November 2026 |
The HSE gave two reasons for ending it early. It found the substance is toxic to reproduction, with effects on fertility1. It also found the substance disrupts human hormones, acting on the oestrogen, androgen and steroid systems1.
The HSE said these problems were clear enough that it did not need independent scientific advice1. It also judged that delaying the decision for further study would be inappropriate1.
How the British review followed the EU
The European Commission decided on 20 May 2024 not to renew dimethomorph in the European Union and Northern Ireland1. That EU decision had no legal effect in Great Britain. But the approval tests in British law are the same as the EU’s1.
The HSE treated the EU findings as new knowledge and proposed a review of the British approval1. The Department for Environment, Food and Rural Affairs (Defra) and the devolved governments consented to the review in April 20251. The HSE then reviewed the science behind the EU decision and comments from producers1.
Which companies were involved?
When the review began, seven companies held authorisations for dimethomorph products in the UK1. Each was given one month to comment1.
| Company | Response to the review |
|---|---|
| BASF | Submitted three toxicology papers |
| Adama Agricultural Solutions | Said it would not comment |
| FMC | Said it would not comment |
| Pan Agriculture | No comments received |
| Arysta LifeScience | No comments received |
| Clayton Plant Protection | No comments received |
| Gowan UK | No comments received |
The HSE said it noted and considered each BASF paper1. One BASF paper argued for a milder fertility rating than the one the HSE kept1. The HSE told producers of its final decision on 20 October 20261.
Trade notice and international comments
Britain shared the draft decision with trading partners through the World Trade Organization (WTO) in August 20261. This process, under the WTO agreement on technical barriers to trade, lets other countries comment on rules that may affect their exports. The draft notified to the WTO set out the same two reasons for withdrawal2.
From draft to final decision
On 2 October 2026, the HSE received confirmation that the WTO process had concluded1. It found that comments received did not materially change its decision1.
Transition timeline and key deadlines
Products containing dimethomorph can no longer be authorised in Great Britain1. Existing authorisations must be withdrawn under the British pesticide law1. The HSE set a phased grace period, a set time to run down stocks, because of the risks to people and mammals1.
This gives sellers about six months after the approval ends to clear stock. Growers then have a further year to use or dispose of what they hold.
What changes for growers and suppliers
The decision covers only putting the substance and products containing it on the market1. Firms that sell these products must stop by 31 May 20271. Growers holding stock must use or dispose of it by 31 May 20281.
Deadlines for sellers and growers
The fertility rating behind the decision stays in place under Britain’s chemical labelling rules1. That listing reads "May damage fertility"1.
Key terms in plain words
| Term | Meaning |
|---|---|
| Active substance | The chemical in a pesticide that does the work, here killing fungi |
| Approval | Official permission for a chemical to be used in pesticide products |
| Authorisation | Permission to sell a specific branded pesticide product |
| Endocrine disruptor | A chemical that interferes with the body’s hormones |
| Toxic to reproduction category 1B | A rating for chemicals presumed to harm human fertility |
| Grace period | Time allowed to sell, store or use up remaining stock |
The approval of dimethomorph ends on 30 November 2026, and sales must stop by 31 May 20271.
Sources
- ↩ DECISION TO WITHDRAW APPROVAL OF THE ACTIVE SUBSTANCE https://www.hse.gov.uk/pesticides/assets/docs/pawbsd-abmh-1257.pdf
- ↩ 26_04033_00_e.pdf https://members.wto.org/crnattachments/2026/TBT/GBR/26_04033_00_e.pdf